Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transfusion triggers for blood components.

P Clark1, P D Mintz

  • 1Blood Bank, Clinical Laboratories, and Department of Pathology, University of Virginia Health System, Charlottesville, Virginia 22908, USA. pc4b@virginia.edu

Current Opinion in Hematology
|October 18, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atypical femoral fractures in a Mexican cohort of children and adolescents with osteogenesis imperfecta. Analysis of trajectories.

Acta ortopedica mexicana·2026
Same author

Latin American patients' perceptions on osteoporosis diagnosis and treatment: The IOF Patient Advisory Group in Latin America.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2025
Same author

Joint position on quality indicators for fragility hip fracture in Mexico.

Archives of osteoporosis·2025
Same author

Optimisation of vitamin D status in global populations.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2024
Same author

Subclinical to catastrophic: a range of outcomes in cerebral air embolism.

Emergency radiology·2023
Same author

Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group.

Archives of osteoporosis·2022
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Optimal transfusion therapy requires further research, especially for red blood cells in critical care and coronary artery disease patients. Platelet and fresh frozen plasma transfusion efficacy also needs more investigation for better patient outcomes.

Area of Science:

  • Transfusion Medicine
  • Hematology
  • Critical Care Medicine

Background:

  • Current transfusion therapy guidelines are general, lacking optimization for specific clinical scenarios.
  • Research is increasingly focusing on controlled studies for red blood cell transfusions in defined patient groups.

Purpose of the Study:

  • To highlight the need for optimized transfusion strategies across various clinical settings.
  • To identify areas requiring further research in red blood cell, platelet, and fresh frozen plasma transfusions.

Main Methods:

  • Review of current research on transfusion therapy efficacy.
  • Identification of knowledge gaps in specific patient populations and transfusion products.

Main Results:

Related Experiment Videos

  • Optimal red blood cell transfusion thresholds need further determination for perioperative, coronary artery disease, and intensive care unit patients.
  • The role of chronic transfusion regimens for sickle cell disease requires more research.
  • The value of platelet transfusions for counts between 50,000-100,000 and fresh frozen plasma transfusions needs elucidation.

Conclusions:

  • Further controlled studies are essential to establish optimal transfusion guidelines.
  • Evidence is needed to guide the use of platelet and fresh frozen plasma transfusions in specific hematologic conditions and counts.